Travecta Therapeutics | 394 followers on LinkedIn. Developing a proprietary pipeline of molecules that cross the BBB to treat disorders of the central nervous system. | Travecta is an emerging biotech company utilizing its novel Blood-Brain Barrier Transport Platform to develop a proprietary pipeline of molecules that treat disorders of the central nervous system. The Travecta Platform leverages our proprietary knowledge of the MFSD2a Transport for the targeted delivery of therapeutic agents to the brain. Our platform and know-how allow us to identify and categorize small molecules for enabling their transport across the blood-brain barrier (BBB).
View Top Employees from Travecta TherapeuticsWebsite | http://www.travectatx.com |
Employees | 8 (8 on RocketReach) |
Founded | 2017 |
Technologies |
JavaScript,
HTML,
PHP
+18 more
(view full list)
|
Industry | Biotechnology |
Looking for a particular Travecta Therapeutics employee's phone or email?
Gemma Thomas is the Senior Director, Research and Development of Travecta Therapeutics.
8 people are employed at Travecta Therapeutics.